Moreover, in the patient cohort analysis, patients with high SMYD2 expression had a poor prognosis in terms of recurrence- and metastasis-free survival, implying that SMYD2 function is strongly related to lung cancer proliferation and metastasis (Fig. 1c). Here, SMYD2 is linked to lung carcinoma.